ResearchPUBMEDMay 1
Patent Analysis Perspectives on China's Orphan Drug R&D: Status and Technology Characteristics.
Researchers studied patent applications from China between 1995 and 2023 to understand how many new orphan drugs (medicines for rare diseases) are being developed there. They found that China filed 58% more patent applications for rare disease treatments between 2018 and 2023, with most focus on cancer and brain diseases. This shows China is investing more in rare disease research, especially after new government policies were put in place.
WHY IT MATTERSPatients with rare diseases in China and globally benefit when more countries invest in orphan drug development, as increased competition and innovation can lead to more treatment options and potentially lower costs.
ℹ Good to know